PFM Health Sciences, LP

Position in NVO — Novo Nordisk A S

CIK 1442756 SAN FRANCISCO, CA

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,704,867

+$5,458,466 QoQ

Shares Held

265,016

+34.4% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

1.10%

of 13F equity value

Holder Rank

#138

of 1,348 holders

Holding Since

Dec 2024

3 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Dec 31, 2024

CallValue

$28,808,098

CallShares

334,900

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

PFM Health Sciences, LP holds $87,605,755 across 4 Drug Manufacturers - General names. NVO ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	39,258	$47,087,226
2	MRK	Merck & Co., Inc.	127,118	$16,334,663
3	NVO	Novo Nordisk A S This page	265,016	$12,704,867
4	GILD	Gilead Sciences, Inc.	90,858	$11,478,999

All Filings in NVO

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,704,867	265,016	+34.4%	Shares	Defined	2026-08-14
2026-03-31	$7,246,401	197,181	—	Shares	Defined	2026-05-15
2024-12-31	$28,808,098	334,900	—	Call	Defined	2025-02-14
No filing history on record for this holder in this stock.